D Nzaramba

462 total citations
8 papers, 318 citations indexed

About

D Nzaramba is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, D Nzaramba has authored 8 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Virology and 5 papers in Epidemiology. Recurrent topics in D Nzaramba's work include HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (3 papers) and HIV, Drug Use, Sexual Risk (2 papers). D Nzaramba is often cited by papers focused on HIV Research and Treatment (5 papers), HIV/AIDS Research and Interventions (3 papers) and HIV, Drug Use, Sexual Risk (2 papers). D Nzaramba collaborates with scholars based in Rwanda and Belgium. D Nzaramba's co-authors include Philippe Van de Perre, Nathan Clumeck, Michel Caraël, Susan Allen, Jos Bogaerts, Dominique Rouvroy, François Nsengumuremyi, P. Lepage, J.P. Butzler and S. Sprecher-Goldberger and has published in prestigious journals such as The Lancet, Journal of Clinical Microbiology and American Journal of Ophthalmology.

In The Last Decade

D Nzaramba

8 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Nzaramba Rwanda 7 154 146 99 64 53 8 318
N Desmond United Kingdom 8 137 0.9× 244 1.7× 106 1.1× 66 1.0× 28 0.5× 24 311
P D Woolley United Kingdom 11 316 2.1× 90 0.6× 33 0.3× 30 0.5× 25 0.5× 45 447
Rachel Weinrib United States 10 141 0.9× 294 2.0× 36 0.4× 216 3.4× 52 1.0× 15 481
Kiwan Stewart United States 5 240 1.6× 240 1.6× 94 0.9× 49 0.8× 26 0.5× 6 350
Hakima Himmich Morocco 12 140 0.9× 139 1.0× 20 0.2× 37 0.6× 21 0.4× 38 339
I Spigland United States 9 172 1.1× 102 0.7× 48 0.5× 13 0.2× 58 1.1× 15 319
AntheaJ. Tilzey United Kingdom 13 241 1.6× 149 1.0× 34 0.3× 33 0.5× 76 1.4× 21 443
Agnès Libois Belgium 11 165 1.1× 145 1.0× 30 0.3× 25 0.4× 65 1.2× 38 374
Ken McLean United Kingdom 11 192 1.2× 282 1.9× 165 1.7× 96 1.5× 42 0.8× 22 479
Francis K. Lee United States 8 186 1.2× 75 0.5× 101 1.0× 12 0.2× 18 0.3× 10 315

Countries citing papers authored by D Nzaramba

Since Specialization
Citations

This map shows the geographic impact of D Nzaramba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Nzaramba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Nzaramba more than expected).

Fields of papers citing papers by D Nzaramba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Nzaramba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Nzaramba. The network helps show where D Nzaramba may publish in the future.

Co-authorship network of co-authors of D Nzaramba

This figure shows the co-authorship network connecting the top 25 collaborators of D Nzaramba. A scholar is included among the top collaborators of D Nzaramba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Nzaramba. D Nzaramba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Perre, Philippe Van de, J Batungwanayo, Philippe Kestelyn, et al.. (1988). Herpes Zoster in African Patients: An Early Manifestation of HIV Infection. Scandinavian Journal of Infectious Diseases. 20(3). 277–282. 52 indexed citations
2.
Perre, Philippe Van de, et al.. (1988). Comparison of six serological assays for human immunodeficiency virus antibody detection in developing countries. Journal of Clinical Microbiology. 26(3). 552–556. 21 indexed citations
3.
Perre, Philippe Van de, A De Clercq, J. Cogniaux-Leclerc, et al.. (1988). Detection of HIV p17 antigen in lymphocytes but not epithelial cells from cervicovaginal secretions of women seropositive for HIV: implications for heterosexual transmission of the virus.. Sexually Transmitted Infections. 64(1). 30–33. 40 indexed citations
4.
Caraël, Michel, Philippe Van de Perre, P. Lepage, et al.. (1988). Human immunodeficiency virus transmission among heterosexual couples in Central Africa.. PubMed. 2(3). 201–5. 98 indexed citations
5.
Perre, Philippe Van de, et al.. (1987). Risk factors for HIV seropositivity in selected urban-based Rwandese adults.. PubMed. 1(4). 207–11. 27 indexed citations
6.
Perre, Philippe Van de, et al.. (1987). HIV antibodies in a remote rural area in Rwanda, Central Africa: an analysis of potential risk factors for HIV seropositivity.. AIDS. 1(4). 213–5. 22 indexed citations
7.
Rouvroy, Dominique, et al.. (1985). Short-term results with suramin for AIDS-related conditions [letter]. The Lancet. 1(8433). 2 indexed citations
8.
Kestelyn, Philippe, Philippe Van de Perre, Dominique Rouvroy, et al.. (1985). A Prospective Study of the Ophthalmologic Findings in the Acquired Immune Deficiency Syndrome in Africa. American Journal of Ophthalmology. 100(2). 230–238. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026